inner-banner-bg

Journal of Gastroenterology & Digestive Systems(JGDS)

ISSN: 2640-7477 | DOI: 10.33140/JGDS

Impact Factor: 1.13

Lisiya S

Department of Pharmacy, Sri Ramachandra Institute of Higher Education and Research, India

Publications
  • Research Article   
    A Systematic Review on Vonoprazan Fumarate Used in the Treatment of Gerd
    Author(s): Kiran Khanna D, Lisiya S, Rahul Kannan M and Karthik Thiyagarajan*

    Vonoprazan is a potassium competitive acid blocker, has shown potential used to treat acid reflux and eliminating Helicobacter pylori. Its enhanced anti-secretory action, quick action, and reduced anti-secretory variability make it a more suitable option than PPIs. However, many researches are needed to fully understand the effects and its safety and tolerability profiles. The drug's effectiveness in treating reflux esophagitis is also reviewed. Due to the limits and unfulfilled therapeutic needs of proton pump inhibitors (PPIs), new medications also developed to address acid-related disorders and the elimination of H. pylori. Vonoprazan, a recently developed potassium-competitive acid blocker (P-CAB), demonstrated greater inhibition of stomach acid secretion. The effectiveness of vonoprazan in treating illnesses linked to acid reflux is reviewed in this paper, with an emphasis on.. Read More»

    Abstract HTML PDF